MedPath

Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases

Not Applicable
Completed
Conditions
Malnutrition
Liver Diseases, Alcoholic
Registration Number
NCT02319252
Lead Sponsor
University of Aarhus
Brief Summary

The study is an unblinded randomized trial, designed to examine whether gastric- or jejunal feeding tubes are the most effect full to feed patients with alcoholic liver diseases and non-sufficient oral intake.

The primary outcome will be differences in nutrition intake between the groups. Secondary outcomes will be: the amount of unplanned tube discontinuations; handgrip and patients' quality of life, nausea \& vomiting.

The study will include 40 patients at Aarhus University Hospital, Denmark.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Alcoholic liver disease
  • nutrition intake less than 75% of needed intake
  • Signed informed consent form
Exclusion Criteria
  • Hepatic encephalopathy, grade 3 - 4
  • Anatomic barriers to have a tube placed

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Differences in nutrition intakeDay 3 & 7 and every 7th. day until discharge from the hospital, up to 3 months

Nutrition intake, protein intake, oral intake versus tube intake

Secondary Outcome Measures
NameTimeMethod
Differences in patients reported outcomesDay 3 & 7 and every 7th. day until discharge from the hospital, up to 3 months

Questionnaires

Trial Locations

Locations (1)

Aarhus University Hospital

🇩🇰

Aarhus, Central Region, Denmark

Aarhus University Hospital
🇩🇰Aarhus, Central Region, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.